Redsense Medical AB (REDS) - Total Liabilities
Based on the latest financial reports, Redsense Medical AB (REDS) has total liabilities worth Skr3.89 Million SEK (≈ $418.95K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Redsense Medical AB - Total Liabilities Trend (2020–2024)
This chart illustrates how Redsense Medical AB's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Redsense Medical AB to evaluate short-term liquidity relative to the company's equity base.
Redsense Medical AB Competitors by Total Liabilities
The table below lists competitors of Redsense Medical AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
DIGIDRIVE DISTRIBUTORS LTD
NSE:DIGIDRIVE
|
India | Rs383.10 Million |
|
NINE MILE METALS LTD
F:KQ9
|
Germany | €333.04K |
|
Norfolk Metals Ltd
AU:NFL
|
Australia | AU$166.78K |
|
Mahaka Media Tbk
JK:ABBA
|
Indonesia | Rp354.46 Billion |
|
Durango Resources Inc.
V:DGO
|
Canada | CA$729.65K |
|
EMC Public Company Limited
BK:EMC
|
Thailand | ฿714.63 Million |
|
Forum Energy Metals Corp
V:FMC
|
Canada | CA$3.22 Million |
|
UET United Electronic Technology AG
XETRA:CFC
|
Germany | €49.88 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Redsense Medical AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see REDS market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Redsense Medical AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Redsense Medical AB (2020–2024)
The table below shows the annual total liabilities of Redsense Medical AB from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr2.21 Million ≈ $238.05K |
-35.13% |
| 2023-12-31 | Skr3.41 Million ≈ $366.97K |
-4.80% |
| 2022-12-31 | Skr3.58 Million ≈ $385.48K |
-37.78% |
| 2021-12-31 | Skr5.76 Million ≈ $619.55K |
+4.58% |
| 2020-12-31 | Skr5.51 Million ≈ $592.43K |
-- |
About Redsense Medical AB
Redsense Medical AB (publ) develops a monitoring system to detect sign of a blood leak using patented fiber optic technology primarily in Europe, Canada, and the United States. The company offers Redsense System, a product that is used for monitoring and alarming in the case of blood leakage during hemodialysis treatment; and Redsense venous sensor patch, a noninvasive patch that consists of an o… Read more